Fate Therapeutics, Inc, based in San Diego, CA, is a biotechnology company dedicated to transforming the lives of patients with cancer and autoimmune disorders through innovative cellular therapy. With a focus on developing novel product candidates like FT576, FT522, FT819, and FT825, Fate Therapeutics aims to harness the power of iPSC technology to create personalized treatments.
Driven by a mission to deliver cutting-edge solutions, Fate Therapeutics boasts a robust pipeline, a talented management team, and a commitment to corporate responsibility. Through their pioneering work in science, manufacturing, and collaborations, the company continues to pave the way for advancements in the field of cellular therapy.
Generated from the website